EOLIA
2018
Extracorporeal Membrane Oxygenation for Severe ARDS
In 249 patients with very severe ARDS, early VV-ECMO did not significantly reduce 60-day mortality versus conventional ventilation with rescue ECMO.
Result
Efficacy: 60-day mortalityRR 0.76 (95% CI 0.55-1.04) · P = 0.09
Below 1 favours early VV-ECMO, above 1 favours conventional ventilation with rescue ECMO.
- Absolute difference
- 11 points
The absolute difference is derived from the event rates.
Also reported: 28% crossover to ECMO. Bayesian re-analysis favoured ECMO.
- Subtopic
- ECMO
- Design
- Multicentre RCT, stopped early
- Relevance
- Important: one of several pillars.
- Source
- Combes A, et al. N Engl J Med. 2018;378(21):1965-1975.doi 10.1056/NEJMoa1800385
Discussion & critique
With Bayesian re-analysis supports VV-ECMO as rescue at experienced centres.